Insulin Secretion and Insulin Sensitivity Pattern Is Different in Isolated Impaired Glucose Tolerance and Impaired Fasting Glucose
The Risk Factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes Study
- Markolf Hanefeld, MD, PHD1,
- Carsta Koehler, PHD1,
- Katja Fuecker, DIPL CHEM2,
- Elena Henkel, MD1,
- Frank Schaper, MD2 and
- Theodora Temelkova-Kurktschiev, MD, PHD1
- 1Centre for Clinical Studies, Gesellschaft für Wissens-und Technologietransfer, Technical University Dresden, Dresden, Germany
- 2Institute for Clinical Metabolic Research, Medical Faculty, Technical University Dresden, Dresden, Germany
Abstract
OBJECTIVE—Isolated impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) are two risk categories for type 2 diabetes. This study compared both categories with respect to the degree of insulin secretion abnormalities and insulin resistance.
RESEARCH DESIGN AND METHODS—This is a crossover comparison of a population at high risk for type 2 diabetes. The subjects were recruited from the Risk Factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes (RIAD) study. They underwent a 75-g oral glucose tolerance test, with measurement of specific insulin, C-peptide, proinsulin, and free fatty acids at baseline and every 30 min after load for 2 h. Factor analysis was performed to evaluate the importance of insulin resistance and secretion abnormalities in both categories.
RESULTS—All categories of prediabetic hyperglycemia had a higher cardiovascular risk factor level when adjusted for sex, age, and BMI compared to control subjects with normal glucose tolerance. Subjects with isolated IFG were more insulin resistant than those with IGT. By contrast, subjects with isolated IGT exhibited a more severe deficit in early- and late-phase insulin secretion versus IFG subjects. As shown with factor analysis, in IFG the insulin resistance factor explained 28.4% of the variance, whereas in IGT the insulin secretion factor was dominant, explaining 31.1% of the total variance.
CONCLUSIONS—Our cross-sectional data from the RIAD study demonstrate that isolated IFG and isolated IGT are different with respect to the degree of insulin resistance and anomalies in insulin secretion, and that subjects with IGT exhibit a deficit in the early and late phases of insulin secretion. This finding may be important for a differential approach in primary prevention of type 2 diabetes.
- AUC, area under the curve
- CGI, combined glucose intolerance
- CV, coefficient of variation
- FFA, free fatty acid
- FPG, fasting plasma glucose
- HOMA, homeostasis model assessment
- IFG, impaired fasting glucose
- IGT, impaired glucose tolerance
- inc AUC, incremental AUC
- IR-HOMA, HOMA insulin resistance index
- NGT, normal glucose tolerance
- OGTT, oral glucose tolerance test
- PG, plasma glucose
- RIAD study, Risk Factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study
- WHO, World Health Organization.
Footnotes
-
Address correspondence and reprint requests to Markolf Hanefeld, MD, PhD, Gesellschaft für Wissensund Technologietransfer der TU Dresden, Zentrum für Klinische Studien, Fiedlerstraβe 34, 01307 Dresden, Germany. E-mail: hanefeld{at}gwt-tud.de.
Received for publication 26 June 2002 and accepted in revised form 4 December 2002.
A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.
- DIABETES CARE











